Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.22 USD | +2.12% | +5.81% | -23.08% |
23/04 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
22/04 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.08% | 8.23B | |
+9.67% | 106B | |
-0.12% | 104B | |
+6.49% | 23.25B | |
-13.78% | 22.5B | |
-6.73% | 18.7B | |
-37.08% | 17.95B | |
-10.70% | 16.99B | |
+7.53% | 14.26B | |
+38.91% | 12.76B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Biotech Q4 Loss Widens, Revenue Slips YOY